A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
In-silico analysis of potential interaction of drugs and the SARS-CoV-2 spike protein
[post]
2020
unpublished
The world is suffering its deadly pandemic in decades from Corona virus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Till the end of April, 2020, the death toll rose to more than 2 lacs worldwide (224 301, on May 1st), affecting 215 countries (source: WHO). Since the invention of a new drug or vaccine takes time, drug repurposing is one of the avenues. Keeping that in mind, we have tried to shed light on some of the drugs, using molecular
doi:10.21203/rs.3.rs-30401/v1
fatcat:heqdym6n3rahljgwajy4lwe2oa